Search research articles
Contact Us
Filters
Showing results (511-520 of 539) with videos related to
Page
of 54
Sort By:
Gynecologic Oncology
|
July 19, 2022
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial
Dana M Chase, Margarita Romeo Marín, Floor Backes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 1, 2024
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study
Whitney S Graybill, Beatriz Pardo Búrdalo, David M O'Malley, et al.
The Journal of Trauma and Acute Care Surgery
|
May 31, 2023
Committee on Surgical Combat Casualty Care position statement: Neurosurgical capability for the optimal management of traumatic brain injury during deployed operations
Jennifer M Gurney, Matthew D Tadlock, Bradley A Dengler, et al.
The Journal of Trauma and Acute Care Surgery
|
April 20, 2017
Multi-institutional, prospective, observational study comparing the Gastrografin challenge versus standard treatment in adhesive small bowel obstruction
Martin D Zielinski, Nadeem N Haddad, Daniel C Cullinane, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 18, 2008
Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists
Angel I Morales-Ramos, John S Mecom, Terry J Kiesow, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 29, 2025
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study
Whitney S Graybill, Beatriz Pardo Búrdalo, David M O'Malley, et al.
Gynecologic Oncology
|
June 4, 2024
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Giorgio Valabrega, Bhavana Pothuri, Ana Oaknin, et al.
Military Medicine
|
September 7, 2018
Burn Casualty Care in the Deployed Setting
Ian R Driscoll, Elizabeth A Mann-Salinas, Nathan L Boyer, et al.
Journal of the National Cancer Institute
|
September 30, 2011
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death
Alpa M Nick, Rebecca L Stone, Guillermo Armaiz-Pena, et al.
The Journal of Trauma and Acute Care Surgery
|
November 9, 2017
The American Association for the Surgery of Trauma Severity Grade is valid and generalizable in adhesive small bowel obstruction
Matthew C Hernandez, Nadeem N Haddad, Daniel C Cullinane, et al.
Page
of 54
Search research articles
Search
Showing results (511-520 of 539) with videos related to
Sort By:
Page
of 54
Gynecologic Oncology
|
July 19, 2022
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial
Dana M Chase, Margarita Romeo Marín, Floor Backes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 1, 2024
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study
Whitney S Graybill, Beatriz Pardo Búrdalo, David M O'Malley, et al.
The Journal of Trauma and Acute Care Surgery
|
May 31, 2023
Committee on Surgical Combat Casualty Care position statement: Neurosurgical capability for the optimal management of traumatic brain injury during deployed operations
Jennifer M Gurney, Matthew D Tadlock, Bradley A Dengler, et al.
The Journal of Trauma and Acute Care Surgery
|
April 20, 2017
Multi-institutional, prospective, observational study comparing the Gastrografin challenge versus standard treatment in adhesive small bowel obstruction
Martin D Zielinski, Nadeem N Haddad, Daniel C Cullinane, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 18, 2008
Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists
Angel I Morales-Ramos, John S Mecom, Terry J Kiesow, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 29, 2025
Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study
Whitney S Graybill, Beatriz Pardo Búrdalo, David M O'Malley, et al.
Gynecologic Oncology
|
June 4, 2024
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Giorgio Valabrega, Bhavana Pothuri, Ana Oaknin, et al.
Military Medicine
|
September 7, 2018
Burn Casualty Care in the Deployed Setting
Ian R Driscoll, Elizabeth A Mann-Salinas, Nathan L Boyer, et al.
Journal of the National Cancer Institute
|
September 30, 2011
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death
Alpa M Nick, Rebecca L Stone, Guillermo Armaiz-Pena, et al.
The Journal of Trauma and Acute Care Surgery
|
November 9, 2017
The American Association for the Surgery of Trauma Severity Grade is valid and generalizable in adhesive small bowel obstruction
Matthew C Hernandez, Nadeem N Haddad, Daniel C Cullinane, et al.
Page
of 54